Find out how higher dose aflibercept may reduce injection burden while preserving vision in retinal vasculopathy.
South Korea: In a post hoc analysis of the randomized PULSAR trial, aflibercept 8 mg demonstrated noninferior visual outcomes ...
The most-read ophthalmology biosimilar stories of 2025 included FDA approvals and real-world data. The continued expansion of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback